Dr. Ashley Brittany Wentworth, MD

Dr. Wentworth practices at Advanced Dermatology And Cosmetic Surgery in Maitland, Florida.

Dr. Wentworth's NPI, 1932526209, was assigned on March 25, 2014. Dr. Wentworth graduated from Mayo Clinic Alix School of Medicine - Rochester in 2014. Dr. Wentworth holds Florida license ME145103.

Dr. Wentworth's primary practice is Advanced Dermatology and Cosmetic Surgery, at 151 Southhall Ln, Maitland, FL 32751. The practice phone is (407) 333-4200.

Dr. Wentworth's primary practice is Advanced Dermatology And Cosmetic Surgery in Maitland, Florida. Dr. Wentworth is also affiliated with Mayo Clinic Hospital. The medical group on file is Mayo Clinic Jacksonville. Dmand AI also links Dr. Wentworth to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wentworth practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Wentworth's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Wentworth is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Wentworth's licenses on file in 3 states: Florida, Minnesota and Ohio.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives and itchy rashes among the conditions Dr. Wentworth treats.

CMS data shows 3,022 Medicare services from Dr. Wentworth across 15 procedure codes in 2024, for 599 Medicare patients. Medicare paid $110,735 for them.

CMS counts 599 Medicare patients who saw Dr. Wentworth in 2024. The largest group is 65 to 74, with 240 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wentworth's median patient age at 65, with 52% women.

In 2024, Dr. Wentworth wrote 781 Medicare Part D claims for 310 patients. 97% of them were for generic drugs. CMS names the drug for 661 of them, across 13 drugs with 11 or more claims each, at $14,345 in total drug cost. In 2023, CMS named 696 claims across 15 drugs.

Dr. Wentworth accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 589 procedures of skin biopsy by Dr. Wentworth, more than 97% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Wentworth, published from 2012 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Dermatitis, Allergic Contact, Allergens and Minnesota. Dr. Wentworth has published most often in Dermatitis. Dr. Wentworth's most frequent co-authors are Lisa A. Drage, MD, Megha M. Tollefson, MD and Asma Javed Chattha, MBBS.

CMS Open Payments shows 76 general payments to Dr. Wentworth from 17 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 95% of the total. Janssen Pharmaceuticals, Inc paid the most, $387.

Dr. Wentworth graduated from Mayo Clinic Alix School of Medicine - Rochester in 2014.

Dr. Wentworth is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.